Please wait
false 0000820313 0000820313 2026-05-21 2026-05-21 0000820313 us-gaap:CommonClassAMember 2026-05-21 2026-05-21 0000820313 us-gaap:CommonClassBMember 2026-05-21 2026-05-21 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 21, 2026

 

AMPHENOL CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware   1-10879   22-2785165

(State or other jurisdiction of incorporation)

  (Commission File Number)   (IRS Employer Identification No.)

 

358 Hall Avenue, Wallingford, Connecticut   06492
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (203) 265-8900

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Class A Common Stock, $0.001 par value APH New York Stock Exchange
3.125% Senior Notes due 2032 APH32 New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

The annual meeting of stockholders of Amphenol Corporation (the “Company”) was held on May 21, 2026.  As of March 23, 2026, the record date for the meeting, 1,229,430,709 shares of Class A Common Stock, par value $.001 per share (“Common Stock”) were outstanding.  A quorum of 1,121,383,291 shares were present or represented at the meeting.

 

The stockholders (i) elected each of the Company’s nominees for director, (ii) ratified the selection of Deloitte & Touche LLP as independent public accountants of the Company, and (iii) approved the advisory vote to approve compensation of named executive officers.  The voting results for each item, all of which are described in the Company’s Proxy Statement filed with the Securities and Exchange Commission on April 8, 2026, are as follows:

 

1. ELECTION OF EIGHT DIRECTORS

 

FOR the nominees:

 

NOMINEE  FOR   AGAINST   ABSTAIN   NON-VOTES 
Nancy A. Altobello  1,060,354,260   12,136,716   226,738   48,665,577 
David P. Falck  1,019,588,710   51,238,137   1,890,867   48,665,577 
Sanjiv Lamba  1,061,622,681   10,849,424   245,609   48,665,577 
Rita S. Lane  1,066,823,967   5,662,734   231,013   48,665,577 
Robert A. Livingston  1,043,851,235   28,626,974   239,505   48,665,577 
R. Adam Norwitt  1,014,364,065   58,062,011   291,638   48,665,577 
Prahlad Singh  1,063,901,047   8,572,596   244,071   48,665,577 
Anne Clarke Wolff  1,064,478,936   8,011,199   227,579   48,665,577 

 

2. RATIFICATION OF THE SELECTION OF DELOITTE & TOUCHE LLP AS INDEPENDENT PUBLIC ACCOUNTANTS

  

FOR  1,048,449,127  AGAINST  72,154,410 
           
ABSTAIN  779,754  NON-VOTES  0 

 

3.ADVISORY VOTE TO APPROVE COMPENSATION OF NAMED EXECUTIVE OFFICERS

 

FOR  984,297,730  AGAINST  83,096,067 
           
ABSTAIN  5,323,917  NON-VOTES  48,665,577 

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Document Description
     
104   Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

 

 

 

 

Signature

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    AMPHENOL CORPORATION
     
  By: /s/ Lance E. D’Amico
    Lance E. D’Amico
    Executive Vice President, Secretary and General Counsel
     
Date: May 22, 2026